European Society for Medical Oncology

What European Society for Medical Oncology does

The European Society for Medical Oncology (ESMO) is a Swiss-registered, non-profit professional medical oncology society founded in 1975 and headquartered in Lugano, Switzerland. It serves practicing oncologists, cancer researchers, and allied healthcare professionals, with operations spanning scientific publishing, congress organization, professional education, and policy advocacy.

ESMO operates a multi-channel professional platform. Its public-facing website portal and member-only OncologyPRO resource distribute clinical guidelines, educational material, and curated oncology content. Daily Reporter provides congress news coverage, while the society's peer-reviewed journals — including Annals of Oncology and ESMO Open — anchor its scientific publishing activity, with additional ESMO-branded journals slated for launch in 2026. The congress portfolio includes the flagship ESMO Congress alongside disease-specific meetings such as the ESMO Gastrointestinal Cancers Congress 2026.

The society's business model rests on individual membership dues, registration and exhibition revenue from recurring congresses, publication royalties, and institutional partnerships. It maintains a formal partnership with the World Health Organization and conducts regulatory advocacy on European policy instruments including the Tobacco Products Directive, the In Vitro Diagnostics Regulation (IVDR), and the proposed EU Biotech Act. ESMO does not disclose revenue, headcount, or detailed pricing in the available material, and its non-profit structure means there are no funding rounds or ownership transactions to assess.

Name

European Society for Medical Oncology

Legal name

European Society for Medical Oncology

Website

https://esmo.org

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

51–100 employees

Short description

The European Society for Medical Oncology (ESMO) is a Swiss non-profit professional society, founded in 1975, serving oncologists and cancer researchers through membership, peer-reviewed publishing, congress organization, and policy advocacy.

Ownership category

akta.pro rank

Product category

Professional Medical Society Services

NAICS

Convention and Trade Show Organizers (561920)

SIC

Services-Membership Organizations (8600)

akta.pro industry

PRIMARYHLAKAFAB

Medical Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYBPADANAJ

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation

Business & Public Services/International Organizations & Development/International Standards, Policy & Regulatory Cooperation

Keywords

• Medical oncology society
• Professional medical association
• Oncology clinical guidelines
• Oncology research publications
• Continuing medical education

Headquarters

HQ city

Lugano

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: Annual membership fees providing access to scientific resources, clinical guidelines, educational content, and member benefits including newsletters and professional networking.
2. Conference and Event Registration: Revenue from hosting major oncology congresses including registration fees for scientific meetings and educational events.
3. Publications and Educational Resources: Revenue from peer-reviewed journals, educational materials, and scientific publications in the field of medical oncology.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

ESMO is a professional medical society that provides oncology education, clinical practice guidelines, peer-reviewed scientific publications, and hosts scientific congresses for oncology professionals. The organization also advocates for cancer policy at EU and global levels, engages with regulatory bodies (WHO, EMA, FDA), and operates the OncologyPRO digital platform as a professional resource hub. It serves members globally through membership dues, event registration, and publication-related revenues.

Product overview

ESMO is a Swiss-registered not-for-profit professional organization serving the global oncology community. The organization operates a unified digital platform offering multiple integrated products and services: the ESMO Website Portal as the primary gateway, OncologyPRO for professional clinical resources, Daily Reporter for conference coverage, ESMO Journals for peer-reviewed publications including ESMO Open and Annals of Oncology, and hosts specialized congresses such as the ESMO Gastrointestinal Cancers Congress. The portfolio is complemented by policy initiatives and advocacy work focused on equitable cancer care.

Differentiator

Problem solved

Functional benefit

Products and services

• OncologyPRO Professional oncology resource platform offering clinical information, research updates, and educational content for oncology professionals.
• ESMO Journals (Annals of Oncology, ESMO Open) Peer-reviewed oncology publications providing access to cancer research, clinical guidelines, and scientific literature, including established titles Annals of Oncology and ESMO Open, with new journals being added to the portfolio in 2026.
• Daily Reporter Real-time reporting service providing daily coverage of oncology conferences, congresses, and scientific meetings.
• ESMO Membership Annual membership program providing oncology professionals with access to scientific resources, clinical guidelines, educational content, newsletters, and professional networking opportunities.
• ESMO Scientific Congresses (e.g., ESMO Gastrointestinal Cancers Congress 2026) Annual scientific congresses dedicated to specific oncology topics (such as gastrointestinal cancers), featuring research presentations, clinical updates, and professional education for oncology specialists.

Quantifiable outcome

• Given that up to 40% of all cancers are preventable, robust tobacco cessation policies are among the most effective strategies for reducing cancer risk

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• World Health Organization (WHO)coreStrategic or Co-development PartnerESMO engages with WHO on global cancer policy, hailing the publication of the WHO Global Status Report on Cancer as a reference for policymakers, healthcare professionals, patient organisations, and stakeholders working to improve cancer outcomes worldwide.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• American Society of Clinical Oncology (ASCO): ASCO is the leading U.S. professional society for clinical oncology, operating a comparable model of clinical guidelines, journals (JCO), the ASCO Annual Meeting, and policy advocacy. It is the most direct competitor to ESMO for global oncology member mindshare and sponsorship.
• American Association for Cancer Research (AACR): AACR is a major peer-reviewed scientific society that publishes leading oncology journals (Cancer Discovery, Clinical Cancer Research) and hosts one of the largest annual cancer research conferences. It competes with ESMO for oncology researchers, authors, and conference attendance.

Broad incumbents

• European Society for Radiotherapy & Oncology (ESTRO): ESTRO is a European-based professional society serving a neighboring oncology specialty (radiation oncology) with a similar congress-and-publication model. It is comparable to ESMO as a sister European society addressing an adjacent oncology discipline.
• European Hematology Association (EHA): EHA is a European professional society for hematology practitioners, operating congresses, the EHA journal, and educational programs. It is structurally comparable to ESMO and overlaps significantly in member base for hematologic oncology topics.
• American Society of Hematology (ASH): ASH is the largest professional society for hematology worldwide, hosting the annual ASH Meeting and publishing Blood. It overlaps with ESMO's hematologic oncology content and competes for the same specialist audience.
• American Society for Radiation Oncology (ASTRO): ASTRO is the primary U.S. society for radiation oncology, with an annual meeting and peer-reviewed journal. It is comparable to ESMO as a peer oncology specialty society and competes for cross-disciplinary oncology professionals.

Emerging players

• International Association for the Study of Lung Cancer (IASLC): IASLC is a global specialty society focused on thoracic oncology, hosting the World Conference on Lung Cancer and publishing the Journal of Thoracic Oncology. It is comparable to ESMO's disease-specific congress model (e.g., ESMO GI Cancers Congress) and competes for thoracic oncology mindshare.
• Society for Immunotherapy of Cancer (SITC): SITC is a U.S.-based professional society dedicated to cancer immunotherapy, hosting the SITC Annual Meeting and the Journal for ImmunoTherapy of Cancer. It is comparable to ESMO as a specialty oncology society with a growing congress and journal footprint.

Others

• International Society of Paediatric Oncology (SIOP): SIOP is a global professional society for pediatric oncology, hosting the SIOP Congress and publishing Pediatric Blood & Cancer. It is a thematically related society sharing ESMO's congress-and-publication model but focused on a distinct patient population.
• European Medicines Agency (EMA): EMA is the EU regulatory body that reviews and approves oncology therapeutics and is therefore a key counterpart in ESMO's policy and regulatory advocacy work. ESMO regularly cites EMA recommendations in its news flow, making EMA a closely related ecosystem participant rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/myesmo
• LinkedInlinkedin.com/company/european-society-for-medical-oncology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about European Society for Medical Oncology